Samuel George A. III

CIK 00018787321 companyCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001878732

Recent Transactions

22 trades

Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2026-03-05+900,000→ 900,000 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2026-02-11$1.80/sh−2,502→ 31,063 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2026-02-11+6,075→ 33,565 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2026-02-11−6,075→ 0 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-12-19+1,735→ 27,555 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-12-19$1.68/sh−65→ 27,490 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2025-03-10+750,000→ 750,000 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2025-02-11−6,076→ 6,075 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-02-11+6,076→ 28,260 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-02-11$0.65/sh−2,440→ 25,820 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2024-11-26$0.60/sh+15,000→ 22,184 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2024-03-07+650,000→ 650,000 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2024-02-11$1.08/sh−2,490→ 7,184 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2024-02-11−6,076→ 12,151 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2024-02-11+6,076→ 9,674 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2023-03-09+650,000→ 650,000 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2023-02-11−6,076→ 18,227 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2023-02-11$1.35/sh−2,478→ 3,598 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2023-02-11+6,076→ 6,076 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2022-03-10+650,000→ 650,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2022-02-11+24,303→ 24,303 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (right to buy)
2021-09-01+695,000→ 695,000 total

Companies

Lineage Cell Therapeutics, Inc.
General Counsel and Secretary
$LCTX

Recent Filings

Address

C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200

CARLSBAD, CA, 92008

View on SEC.gov